Millipore Sigma Vibrant Logo

551476 InSolution™ Q-VD-OPh, Non-O-methylated - Calbiochem

Descripción

Replacement Information

Tabla espec. clave

Empirical Formula
C₂₆H₂₅F₂N₃O₆

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
551476-1MG
Comprobando disponibilidad...
Disponibilidad a confirmar
Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      Ampolla de plást. 1 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      Solicitar precio
      551476-5MG
      Comprobando disponibilidad...
      Disponibilidad a confirmar
Disponibilidad a confirmar
      Ingrese cantidad 
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        El resto: se avisará
          El resto: se avisará
          Se avisará
          Póngase en contacto con el Servicio de Atención al Cliente
          Contact Customer Service

          Frasco de vidrio 5 mg
          Recuperando precio...
          No pudo obtenerse el precio
          La cantidad mínima tiene que ser múltiplo de
          Maximum Quantity is
          Al finalizar el pedido Más información
          Ahorró ()
           
          Solicitar precio
          Description
          OverviewA cell-permeable, irreversible, broad-spectrum caspase inhibitor (IC50 = 50, 100, 430, and <25 nM for caspase-1,-8, -9, and -3, respectively) with effective antiapoptotic properties against all major caspase-mediated cellular apoptosis pathways. Exhibits no cytotoxic effects even at extremely high concentrations. Shown to reduce ischemic brain damage and stroke-induced programmed cell death in thymus and spleen.
          Catalogue Number551476
          Brand Family Calbiochem®
          SynonymsN-(2-Quinolyl)valyl-aspartyl-(2,6-difluorophenoxy)methyl Ketone
          References
          ReferencesBraun, J.S., et al. 2007. Exp. Neurol. 206, 183.
          Caserta, T.M., et al. 2003. Apoptosis 8, 345.
          Rebbaa, A., et al. 2003. Oncogene 22, 2805.
          Product Information
          ATP CompetitiveN
          FormLiquid
          FormulationSupplied as a 10 mM (1 mg/195 µl) solution in DMSO.
          Hill FormulaC₂₆H₂₅F₂N₃O₆
          Chemical formulaC₂₆H₂₅F₂N₃O₆
          Hygroscopic Hygroscopic
          ReversibleN
          Structure formula ImageStructure formula Image
          Quality LevelMQ100
          Applications
          Biological Information
          Primary Targetcaspase-1
          Primary Target IC<sub>50</sub>50, 100, 430, and <25 nM for caspase-1,-8, -9, and -3, respectively
          Purity≥90% by HPLC
          Physicochemical Information
          Cell permeableY
          Peptide SequenceQ-Val-Asp-CH₂-OPh
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Shipped with Blue Ice or with Dry Ice
          Toxicity Irritant
          Storage -20°C
          Protect from Light Protect from light
          Hygroscopic Hygroscopic
          Do not freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          Número de referencia GTIN
          551476-1MG 04055977268898
          551476-5MG 04055977268904

          Documentation

          Licencias necesarias

          Título
          PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD

          InSolution™ Q-VD-OPh, Non-O-methylated - Calbiochem Ficha datos de seguridad (MSDS)

          Título

          Ficha técnica de seguridad del material (MSDS) 

          InSolution™ Q-VD-OPh, Non-O-methylated - Calbiochem Certificados de análisis

          CargoNúmero de lote
          551476

          Referencias bibliográficas

          Visión general referencias
          Braun, J.S., et al. 2007. Exp. Neurol. 206, 183.
          Caserta, T.M., et al. 2003. Apoptosis 8, 345.
          Rebbaa, A., et al. 2003. Oncogene 22, 2805.

          Folleto

          Cargo
          Caspases and other Apoptosis Related Tools Brochure

          Citas

          Título
        • Braun, J.S., et al. 2007. Exp. Neurol. 206, 183.
        • Jessica H. Dworet and Judy L. Meinkoth. 2006.Molecular Endocrinology 20, 1112.
        • Ademi E. Santiago-Walker, et al. (2005) Protein Kinase C δ Stimulates Apoptosis by Initiating G1 Phase Cell Cycle Progression and S Phase Arrest. Journal of Biological Chemistry 280, 32107-32114.
        • Ficha técnica

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision28-February-2012 RFH
          SynonymsN-(2-Quinolyl)valyl-aspartyl-(2,6-difluorophenoxy)methyl Ketone
          DescriptionA cell-permeable, irreversible, broad-spectrum caspase inhibitor (IC50 = 50 nM for caspase-1; IC50 = 100 nM for caspase-8; IC50 = 430 nM for caspase-9; IC50 < 25 nM for caspase-3). Exhibits effective anti-apoptotic properties against all major caspase-mediated cellular apoptosis pathways, including caspase 9/3, caspase 8/10, and caspase 12. Does not exhibit toxic effects even at high concentrations. To reduce hydrophobicity of the peptide and facilitate its use in aqueous media the aspartyl residue is not O-methylated. Shown to reduce ischemic brain damage and stroke-induced programmed cell death in thymus and spleen.
          FormLiquid
          FormulationSupplied as a 10 mM (1 mg/195 µl) solution in DMSO.
          Intert gas (Yes/No) Packaged under inert gas
          Chemical formulaC₂₆H₂₅F₂N₃O₆
          Peptide SequenceQ-Val-Asp-CH₂-OPh
          Structure formulaStructure formula
          Purity≥90% by HPLC
          Storage Protect from light
          -20°C
          Hygroscopic
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
          Toxicity Irritant
          ReferencesBraun, J.S., et al. 2007. Exp. Neurol. 206, 183.
          Caserta, T.M., et al. 2003. Apoptosis 8, 345.
          Rebbaa, A., et al. 2003. Oncogene 22, 2805.
          Citation
        • Braun, J.S., et al. 2007. Exp. Neurol. 206, 183.
        • Jessica H. Dworet and Judy L. Meinkoth. 2006.Molecular Endocrinology 20, 1112.
        • Ademi E. Santiago-Walker, et al. (2005) Protein Kinase C δ Stimulates Apoptosis by Initiating G1 Phase Cell Cycle Progression and S Phase Arrest. Journal of Biological Chemistry 280, 32107-32114.